You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

 

Online download statistics by month:

Online download statistics by month: February 2023 to October 2025

AbstractFullPdf
Feb 2023437440146
Mar 2023492497236
Apr 2023304305104
May 202316917168
Jun 2023211213116
Jul 202312412542
Aug 202319019039
Sep 2023959529
Oct 2023929442
Nov 202311211234
Dec 2023899446
Jan 2024818339
Feb 2024919243
Mar 2024717263
Apr 2024899369
May 2024616136
Jun 2024939333
Jul 202411711845
Aug 2024464513
Sep 2024606132
Oct 2024717241
Nov 2024707127
Dec 202411411939
Jan 2025787835
Feb 202524424445
Mar 202510810832
Apr 202514314339
May 2025656621
Jun 2025505020
Jul 2025220
Oct 2025111
Total397040081575